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Diagnostic Role of New Mediators and Markers 
of Inflammation in Multiple Injured Patients 
D. N a s t - K o l b 1 , C. Waydhas 1 , M . J o c h u m 2 , M . Spannagl 3 , W . M a c h l e i d t 4 , K . H . 
D u s w a l d 1 , and L . Schweiberer 1 
Introduction 
The major cause of late death after severe b lun t t rauma is (multiple) organ 
failure (OF) , w h i c h is a direct consequence of mediators released dur ing pr imary 
tissue damage and c i rcula tory shock. T o further elucidate the role of inf lammat-
ory mediators i n the development o f O F we performed a prospective study in 
severely in jured patients. I n a second step we examined the early prognostic 
value o f objective biochemical markers for death and the development o f O F 
compared to the In ju ry Severity Score (ISS). 
Patients and Methods 
I n the per iod 1986-1989, t raumat ized patients a r r iv ing at our emergency r o o m 
were included i n the prospective study i f a l l o f the fo l lowing criteria were met: (a) 
severe injuries o f at least t w o body regions (head/brain, thorax, abdomen, 
skeletal system) or three major fractures, (b) age between 16 and 70 years, and (c) 
less than 6 h between accident and admission to the emergency department. A 
to ta l o f 69 p r i m a r y surv iv ing patients entered the study. The mean ISS was 36 
(range, 13-66). Between days 4 and 28, 11 patients died (median survival t ime, 
19, days). O f survivors, 29 suffered f rom O F , and 29 had an event-free recovery. 
Three groups were formed: g roup 1, lethal O F (n = 11); group 2, reversible O F 
(n = 29); g roup 3, no O F (n = 29). 
L a b o r a t o r y testing and recording o f c l inical data was started w i t h i n 30 m i n 
after a r r iva l of the patient in the emergency department and continued on a 6-h 
basis. After 48 h the in terva l was extended to 24 h for a period of 14 days. After 2 
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weeks the clinical course was recorded un t i l either transfer to a general ward or 
death. The biochemical markers studies are shown in the Fig . 1. 
The fo l lowing definitions were used: 
Respiratory failure: need of mechanical vent i la t ion and p 0 2 / F i 0 2 < 280 or 
positive end-expiratory pressure > 8 m m H g for at least 
24 h 
Renal failure: creatinine > 177 μηιοΐ/ΐ for at least 48 h 
Liver failure: b i l i r ub in > 51 μηποΐ/ΐ for at least 48 h 
Disseminated intravascular coagulation: (a) thrombocytes < 1 0 0 x l 0 9 / l or 
fall o f > 30% in 24 n, (b) part ial 
th romboplas t in t ime > 50 s for 
24 h, (c) 22 reptilase t ime > 22 s 
for 24 h 
Neopterin 
Elastase Cathepsin Β 
PMN Granulocytes Macrophages 
>^ Cellular Systems <^  
Phospholipase Α P S T I C R P Lactate 
















Factor VIII Antigen 
Protein C 
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Fig. 1. Biochemical markers in traumatic hemorrhagic shock 
Table 1. Complications {n = 69) 
Incidence 
(n) 
Multiple organ failure 29 
Sepsis 20 
Respiratory Failure 42 
Adult respiratory distress syndrome 17 
Liver failure 42 
Renal failure 17 
Gastrointestinal failure 7 
Disseminated intravascular coagulation 7 
No complications 32 
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Gl failure: endoscopically confirmed ulceration wi th bleeding, acalculous 
cholecystitis 
MultipleOF: Failure of two or more organ systems at the same t ime 
The complications of the 69 patients are shown in Table 1. 
Statistical testing was done w i t h the non parametric W i l c o x o n test for two 
samples. Differences were considered significant w i t h ρ values below 0.05. 
Lactate 
1 2 3 L 5 6 7 8 9 10 11 12 13 14 days 
Fig. 2. Lactate, P M N elastase, and cathepsin Β in groups 1 ( * ) , 2 (O) , and 3 ( + ) 
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Results 
The release o f mediators and indicators of inf lammatory reactions i n the three 
outcome groups is displayed in Figs. 2 -4 for those markers wh ich showed 
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Fig. 3. C-reactive protein, D D fragment, and neopterin in groups 1 ( * ) , 2 (O), and 3 ( + 
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accumulation of lactate (Fig. 3) was observed in non survivors (group 1) 
compared to survivors w i t h organ failure (group 2) throughout 14 days of 
observation. The level of polymorphonuclear leukocyte ( P M N ) elastase (Fig. 2) 
showed a highly significant difference in groups 1 and 2 versus group 3 
throughout the whole observation period and in group 1 versus group 2 after the 
Antithrombin III 
I I J I I 1 I I I I I J I 
Prothrombin 
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Fig. 4. Antithrombin I I I , prothrombin, and t-PA in groups 1 ( * ) , 2 (O), and 3 ( + ) 
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3rd day. Cathepsin Β (Fig. 2) dist inguished patients wi th O F (groups 1 and 2) 
from those w i t h uneventful recovery (group 3) w i t h i n the first 4 days. The 
produc t ion of C-reactive protein; (CRP; F i g 3) was different among a l l outcome 
groups starting on the 3rd day after t rauma. The D-dimer fragment (Fig. 3) o f 
group 3 differed from that o f groups 1 and 2 at arr ival , and the levels of a l l three 
groups differed between days 3 and 5. Neop te r in (Fig. 3 ) was higher i n group 1 
(nonsurvivors) compared to survivors (groups 2 and 3) f rom the 2nd day 
onwards and between groups 2 versus 3 after the 4th post traumatic day. 
A n t i t h r o m b i n I I I (Fig. 4) showed a lower inh ib i to ry act ivi ty i n groups 1 and 2 
versus group 3 al l the t ime and between groups 1 and 2 (nonsurvivors versus 
survivors w i th O F ) after the 1st week. A t arr ival , p r o t h r o m b i n and tissue 
plasminogen activator ( t-PA; F ig 4) distinguished between patients devoloping 
O F (groups 1 and 2) and those having an uneventful recovery (group 3). I n the 
2nd week p ro th rombin differed between survivors and nonsurvivors. 
As O F often started on the 1 day, predict ion o f later O F was possible at 
hospital arr ival , whereas a lethal outcome could be predicted w i t h i n the first 
3 days. The demonstrated mediators showed a reasonable accuracy in predic­
t ing O F and death w i t h a higher va l id i ty than the ISS Table 2. The combina t ion 
of the four factors w i t h prognostic value for death ( P M N elastase, CRP, 
Table 2. Prognostic value for lethal outcome at hospital arrival 3 and at day 4 
ACC Sens Spec PPV NPV 
Lactate 3 ( > 45 mg/dl) 88% 60% 93% 60% 93% 
Elastase ( > 500 ng/ml) 90% 73% 93% 67% 95% 
CRP ( > 20 mg/dl) 88% 67% 98% 86% 95% 
Neopterin ( > nmol/1) 86% 75% 93% 67% 95% 
ISS ( > 50) 80% 36% 88% 36% 88% 
ACC, Accuracy; Sens, sensitivity; Spec, specifity; PPV, positive, predicitive value; 
NPV, negative predictive value. 
Prognostic value at hospital arrival for lactate only. 
Table 3. Prognostic value for organ failure at hospital arrival 
ACC Sens Spec PPV NPV 
Cathepsin B ( > 190 U/ l ) 90% 63% 86% 86% 62% 
Elastase ( > 200 ng/ml) 67% 84% 42% 68% 65% 
Antithrombin I I I ( < 80%) 66% 7 1 % 58% 7 1 % 58% 
Prothrombin ( < 70%) 6 1 % 7 1 % 60% 73% 58% 
D-dimer fragment ( > 12 000 ng/ml) 6 1 % 62% 6 1 % 70% 52% 
t-PA ( > 8 ng/ml) 57% 62% 54% 68% 48% 
ISS ( > 30) 6 1 % 70% 48% 65% 54% 
ACC, Accuracy; Sens, sensitivity; Spec, specifity; PPV, positive, predicitive value; NPV, negative 
predictive value, 
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Table 4. Prognostic value of the combination of four para-
meters for lethal outcome: elastase, CRP, neopterin, lactate 
(minimum of pathological factors) 
3 2 1 
Sensitivity 53% 73% 93% 
Specifity 99% 87% 67% 
PPV 89% 50% 34% 
NPV 92% 95% 98% 
Accuracy 92% 85% 6 1 % 
PPV, Positive predictive value; NPV, negative predicitve 
value. 
neopterin, lactate) further improved the accuracy of predict ion. M o r e than three 
pathological results showed a very h igh risk of death; normal release of al l 
mediators indicated survival (Table 3, 4). 
Summary 
Biochemical mediators showed a significant difference between t raumatized 
patients wi th lethal, reversible, and no organ failure. These objective parameters 
of inf lammat ion might give a more accurate description of injury severity and 
al low a better estimation of risk for O F than many t rauma severity scores. 
